Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.68 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.63 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.61 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.61 |
| ▸ | GLP1R | P43220 | 2/20 | 0.59 |
| ▸ | ECE1 | P42892 | 1/20 | 0.59 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.59 |
| ▸ | CCKBR | P32239 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30176428 | 0.93 | PTH1R (0.70) | TFPIVIPR1VIPR2PTH1RGLP1R | |
| SCHEMBL29624097 | 0.93 | VIPR1 (0.68) | TFPIVIPR1VIPR2PTH1RGLP1R | |
| SCHEMBL31182711 | 0.93 | VIPR1 (0.67) | TFPIVIPR1VIPR2PTH1RGLP1R | |
| SCHEMBL29387006 | 0.93 | TFPI (0.65) | TFPIVIPR1VIPR2PTH1RGLP1R | |
| SCHEMBL30198769 | 0.93 | TFPI (0.65) | TFPIVIPR1VIPR2PTH1R | |
| SCHEMBL30423223 | 0.92 | TFPI (0.64) | TFPIVIPR1VIPR2PTH1RGLP1R | |
| SCHEMBL30495775 | 0.92 | VIPR1 (0.70) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30495732 | 0.91 | VIPR1 (0.66) | TFPIVIPR1VIPR2PTH1RGLP1R | |
| SCHEMBL31683281 | 0.91 | VIPR1 (0.72) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL30495651 | 0.91 | VIPR2 (0.62) | TFPIVIPR1VIPR2PTH1RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190887-A1 | TARGETING G3BP AGGREGATION TO PREVENT NEURODEGENERATION | UNIVERSITY OF SOUTH CAROLINA (US) | 2023-06-22 | — | — | US | disclosed |